Lutetium-177 DOTATATE Production with an Automated Radiopharmaceutical Synthesis System

OBJECTIVE(S): Peptide Receptor Radionuclide Therapy (PRRT) with yttrium-90 ((90)Y) and lutetium-177 ((177)Lu)-labelled SST analogues are now therapy option for patients who have failed to respond to conventional medical therapy. In-house production with automated PRRT synthesis systems have clear ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Aslani, Alireza, Snowdon, Graeme M, Bailey, Dale L, Schembri, Geoffrey P, Bailey, Elizabeth A, Pavlakis, Nick, Roach, Paul J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Oceania Journal of Nuclear Medicine & Biology 2015
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937639/
https://www.ncbi.nlm.nih.gov/pubmed/27408890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937639/
https://www.ncbi.nlm.nih.gov/pubmed/27408890

Ejemplares similares